Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real …

L Degli Esposti, D Sangiorgi, S Buda, E Degli Esposti… - BMJ open, 2016 - bmjopen.bmj.com
Objective The present study investigated the effects of switching to different products of the
same off-patent active substance (brand name or generic) on therapy discontinuation or …

Assessing the impact of alternative patent systems on the cost of health care: the TPPA and HIV treatment in Vietnam

HVJ Moir, B Tenni, D Gleeson… - Asia-Pacific Innovation …, 2014 - papers.ssrn.com
Abstract In the Trans Pacific partnership Agreement (TPPA) negotiations, the United States
has proposed expanded patent protections that will likely impact the affordability of …

Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability

P Dylst, A Vulto, S Simoens - Expert review of pharmacoeconomics …, 2015 - Taylor & Francis
Italy is among the European countries with the lowest uptake of generic medicines. This
paper provides a perspective on the Italian generic medicines retail market. Fast market …

Recurrence of atrial fibrillation after switching from brand to generic atenolol

L Gallelli, F Maida, O Staltari, P Rende… - Journal of …, 2015 - journals.sagepub.com
Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in
patients without a history of myocardial infarction or left ventricular dysfunction. In this article …

[PDF][PDF] Il sotto-utilizzo dei farmaci equivalenti in Italia

A Cartabellotta, C Iacono - Evidence, 2016 - reforming.it
Il Rapporto GIMBE sulla sostenibilità del SSN 2016-20251─ presentato in Senato lo scorso
giugno─ ha indicato come strategia fondamentale per garantire la sopravvivenza della …

Surveillance des consultations à l'urgence et des hospitalisations chez les utilisateurs de médicaments génériques et originaux en cardiologie, au Québec.

J Leclerc - 2017 - library-archives.canada.ca
Les médicaments occupent une place de choix dans la prise en charge des maladies
cardiovasculaires. Les médicaments génériques constituent l'alternative économique …

Influência da utilização de medicamentos genéricos na adesão à terapêutica anti-hipertensiva

PIN Silva - 2022 - repositorio.ipl.pt
Introdução: A Hipertensão Arterial é uma doença crónica e o principal fator de risco para as
doenças cardiovasculares cuja prevalência tem vindo a aumentar em todo o mundo. A …

Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram …

JH Jeong, WM Bahk, YS Woo, KU Lee… - Neuropsychiatric …, 2015 - Taylor & Francis
Objectives The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

[HTML][HTML] Generic formulations of psychotropic medications and treatment response

V Bhat, HC Margolese - Journal of Psychiatry & Neuroscience: JPN, 2017 - ncbi.nlm.nih.gov
Generic formulations of psychotropic medications and treatment response - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

[HTML][HTML] Evaluation of prescriptions authorized between 2010 and 2011 through judicial protection in Bogotá

A Portilla-Pinzón, JJ López… - Rev Fac Med …, 2016 - revistas.unal.edu.co
Introducción. La tutela es una herramienta legal empleada para garantizar el derecho a la
salud en Colombia. Objetivo. Evaluar la racionalidad terapéutica de prescripciones de …